银屑病关节炎与类风湿关节炎患者的死因特异性死亡率比较
基于英国健康改善网络1994–2010年队列,比较银屑病关节炎(PsA)、类风湿关节炎(RA)患者与一般人群的死因特异性死亡率。PsA患者总体及心血管、呼吸、恶性肿瘤、感染死亡率未升高,但自杀死亡风险升高;RA患者心血管、呼吸、恶性肿瘤及感染死亡率均显著升高。
要点
- PsA患者心血管、呼吸、恶性肿瘤及感染死亡率与一般人群无显著差异。
- RA患者心血管、呼吸、恶性肿瘤及感染死亡率较一般人群显著升高。
- PsA和RA患者自杀死亡风险均升高,HR分别为3.03和2.47。
核心结论
- PsA患者除自杀死亡外,总体及死因特异性死亡率风险未升高。
- RA患者心血管、呼吸、恶性肿瘤及感染死亡风险显著高于一般人群。
研究设计与样本
- 基于英国健康改善网络(THIN)的队列研究,纳入1994–2010年18–89岁患者。
- 死因按英国死亡统计分类,每例死亡人工复核,采用竞争风险生存回归计算年龄性别调整和多变量调整HR。
主要发现
- PsA、RA和对照分别观察到470、7004和5269例死亡。
- 所有患者最常见死因为心血管疾病,其次为恶性肿瘤、呼吸系统死亡和感染。
- 约25%死亡原因未知。
- RA患者心血管(1.55,1.44–1.66)、呼吸(1.85,1.72–2.01)、恶性肿瘤(1.18,1.08–1.28)和感染死亡(2.21,2.00–2.44)显著升高。
临床怎么用
- 对RA患者应积极管理心血管、呼吸、恶性肿瘤及感染相关风险。
- 对PsA和RA患者关注自杀风险,必要时进行心理评估和干预。
局限性
- 约25%死亡原因未知,可能影响死因分类准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to examine cause-specific mortality in patients with PsA compared with the general population and compared with patients with RA. METHODS: A cohort study was performed using The Health Improvement Network among patients aged 18-89 years with data from 1994 to 2010. PsA and RA were defined by medical codes, and up to 10 unexposed controls were matched on practice and start date within the practice. Cause of death was classified using categories from UK death statistics. Each death was manually reviewed to ensure appropriate classification. Age- and sex-adjusted hazard ratios (HRs) and multivariable adjusted HRs were calculated using competing risks survival regression. RESULTS: Among patients with PsA (8706), RA (41 752) and unexposed controls (81 573), 470, 7004 and 5269 deaths were observed, respectively. The most common causes of death among all patients were cardiovascular disease, followed by malignancy, respiratory deaths and infection. Cause of death was unknown in ∼25%. Among PsA patients, cardiovascular (1.09, 0.91-1.32), respiratory (0.97, 0.79-1.20), malignancy (1.03, 0.86-1.25) and infection deaths (1.05, 0.79-1.39) were not elevated. Among patients with RA, cardiovascular (1.55, 1.44-1.66), respiratory (1.85, 1.72-2.01), malignancy (1.18, 1.08-1.28) and infection deaths (2.21, 2.00-2.44) were significantly elevated compared with population controls. Although less common, suicide deaths were elevated in PsA and RA (HR 3.03 and 2.47, respectively). CONCLUSION: Overall mortality and cause-specific mortality risk were not elevated among patients with PsA except for suicide deaths. Patients with RA were at increased risk of deaths from cardiovascular, respiratory, cancer and infectious diseases.
引用
- Ogdie A, Maliha S, Shin D, et al. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis. Rheumatology (Oxford). 2017. PMID: 28158384. doi:10.1093/rheumatology/kew502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。